DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment

Information source: Erasmus Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Delirium

Phase: N/A

Status: Recruiting

Sponsored by: Erasmus Medical Center

Official(s) and/or principal investigator(s):
Erwin W. Ista, Dr, Study Director, Affiliation: Erasmus MC University Medical Center Rotterdam/ ZonMw
Mathieu van der Jagt, MD, PhD, Study Director, Affiliation: Department of Intensive Care, Erasmus MC - University Medical Center Rotterdam, Netherlands
Zoran Trogrlic, MSc, Principal Investigator, Affiliation: Department of Intensive Care, Erasmus MC - University Medical Center Rotterdam, Netherlands

Overall contact:
Zoran Trogrlic, MSc, Phone: +31 (0) 10703 0497, Email: z.trogrlic@erasmusmc.nl

Summary

Objective: Delirium is an important and frequently occurring complication in intensive care patients. However, screening and treatment of delirium is not in accordance with current national and international guidelines. The first objective of this prospective study is to describe the barriers and facilitators for guideline adherence. Second, investigators will develop a tailored implementation strategy. Finally, investigators will describe the effects of the tailored implementation on the adherence of the guideline in a pilot study. Design: Current practices, attitudes and deviations from a national (Dutch) delirium guideline will be assessed in a prospective before-measurement. Barriers and facilitators will be identified with surveys and focus group interviews. Adherence to the guideline will be studied in a before-after study in 7 ICUs in the Southwest of the Netherlands. Further, the effect of a multifaceted implementation strategy-guided implementation will be assessed with regard to important clinical outcomes, such as mortality and delirium incidence. Population: Professionals (Physicians/intensivists, nurses' and psychiatrists) and ICU patients. Intervention: The delirium guideline of the Netherlands Society of Intensive Care (NVIC) is implemented in this study. Implementation strategies: Barriers and facilitators will be determined in focus group interviews (n=7) with health care professionals resulting in a tailored guideline implementation strategy. In the development of the strategies specific attention will be paid to sustaining the guideline adherence. Main outcome: 1. Current practices; 2. Barriers and facilitators for guideline adherence; 3. Tailored implementation strategy; 4. Percentage of adherence to the guideline (early screening, prevention and treatment of delirium); 5. Effects of implementation on outcomes (economic, mortality, delirium incidence). Data analysis / power: The main effects, guideline adherence, will be evaluated by comparing the before and after measurements. Calculating from 90% power,2-sided alpha=0. 01, 231 patients per periods will be sufficient to test the proposed adherence of 85%. Economic evaluation: The economic analysis will be performed from a health care perspective. Investigator will calculate and compare the direct medical costs of usual care (before) and care after implementation of the guideline. Additionally, the cost of the tailored guideline implementation process will be calculated. The economic analysis will be a cost-minimalization analysis.

Clinical Details

Official title: Improvement of Care for ICU Patients With Delirium by Early Screening and Treatment

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Delirium guideline adherence

Secondary outcome: Economic evaluation

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Screening delirium by all patients

- Measuring of guide line adherence for all professionals working on the ICU

- Implementation guideline: all professionals

Exclusion Criteria:

- no

Locations and Contacts

Zoran Trogrlic, MSc, Phone: +31 (0) 10703 0497, Email: z.trogrlic@erasmusmc.nl

Erasmus MC Academic Medica Center Rotterdam, Rotterdam, South Holland 3000 CA, Netherlands; Recruiting
Zoran Trogrlic, MSc, Phone: +30 (0) 10 7030497, Email: z.trogrlic@erasmusmc.nl
Additional Information

Starting date: April 2012
Last updated: September 30, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017